$117.47
Value $4.0B
CVSA and LOW stock compared: price, dividend, valuation and results, from SEC filings.
$117.47
Value $4.0B
$227.39
Value $127B
Covista (CVSA) has a market value of $4.0B and Lowe's Companies (LOW) $127B. Over the last year, with dividends, CVSA moved +21.8% and LOW +2.0%. The P/E is 15.6 for CVSA and 19.2 for LOW. Dividend yield: CVSA none, LOW 2.15%.
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
CVSA$4.0B
LOW$127B
LOW is 32 times CVSA
Revenue, 12 months
CVSA$2.0B
LOW$90.4B
LOW is 45 times CVSA
Net income, 12 months
CVSA$257M
LOW$6.6B
LOW is 26 times CVSA
Operating margin
CVSA19.8%
LOW11.4%
8.4 points apart
ROIC
CVSA15.7%
LOW27.6%
11.9 points apart
P/E
CVSA15.6
LOW19.2
LOW is 1.2 times CVSA
Dividend yield
CVSA0.0%
LOW2.2%
2.2 points apart
5-year return
CVSA+259.5%
LOW+6.9%
252.6 points apart
A fainter bar means a negative number. The 5-year return includes dividends.
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
CVSA+259.5%
LOW+6.9%
| Period | CVSAWith dividends | LOWWith dividends |
|---|---|---|
| 1 year since November 14, 2025 | +21.8%Price +21.8% | +2.0%Price -0.2% |
| 3 years since November 16, 2023 | +112.8%+28.6% a yearPrice +112.8% | +19.4%+6.1% a yearPrice +12.4% |
| 5 years since November 15, 2021 | +259.5%+29.2% a yearPrice +259.5% | +6.9%+1.3% a yearPrice -3.2% |
| 10 years since November 16, 2016 | +317.6%+15.4% a yearPrice +315.1% | +309.8%+15.1% a yearPrice +239.3% |
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
As on each company's page. A description, not a recommendation: no one figure says which is better.
CVSACovistaLOWLowe's Companies
| Price | $117.47 | $227.39 |
|---|---|---|
| Market value | $4.0B | $127B |
| Enterprise value (EV) | $4.3B | $162B |
| P/E | 15.6 | 19.2 |
| P/E, 5-year median | 17.7 | 21.2 |
| P/B | 2.8 | – |
| EV/EBIT | 10.8 | 15.7 |
| Free cash flow yield | 8.9% | 5.5% |
| Revenue, 12 months | $2.0B | $90.4B |
|---|---|---|
| Net income, 12 months | $257M | $6.6B |
| Free cash flow, 12 months | $355M | $7.0B |
| Earnings per share, 12 months | $7.31 | $11.83 |
| Revenue growth, year on year | 9.3% | 3.1% |
| Revenue growth a year, past | +16.8%over 5 years | -0.8%over 5 years |
| EPS growth a year, past | +38.9%over 5 years | +8.9%over 5 years |
| Gross margin | 57.4% | 33.1% |
|---|---|---|
| Operating margin | 19.8% | 11.4% |
| Net margin | 12.8% | 7.3% |
| ROIC | 15.7% | 27.6% |
| ROE | 18.2% | – |
| Cash | $222M | $3.4B |
|---|---|---|
| Total debt | $754M | $42.0B |
| Net debt / EBITDA | 0.6 | 2.7 |
| Interest cover | 8.9× | – |
| Dividend yield | – | 2.2% |
|---|---|---|
| Dividend per share, 12 months | – | $4.90 |
| Dividend growth a year, past | – | +15.6%over 5 years |
| Buyback yield | 6.0% | 0.2% |
| Shareholder yield | 6.0% | 2.3% |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
By market value, Lowe's Companies ($127B) is about 31.8 times Covista ($4.0B), at today's prices.
Since November 16, 2016, CVSA's price moved +315.1% and LOW's +239.3%. With dividends: CVSA +317.6% (+15.4% a year), LOW +309.8% (+15.1% a year). Past returns do not predict future ones.
The dividend yield at today's price is none for Covista and 2.15% for Lowe's Companies. Over the last twelve months they paid – and $4.90 per share.
At today's price, the P/E is 15.6 for CVSA and 19.2 for LOW. The median of the last five years was 17.7 and 21.2, which shows where each stands against its own past.
Over the last twelve months, the net margin was 12.8% for Covista and 7.3% for Lowe's Companies, and the operating margin 19.8% and 11.4%. Revenue was $2.0B and $90.4B.
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
With each of the two, and with the largest in its sector.
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
Descriptive data from SEC filings and market prices.